Dear readers,
For nearly all of our existence as a species — somewhere between 100,000 and 200,000 years — humans rarely lived past forty. Childhood was treacherous, infection was common, and the body’s elegant design was tuned to a single biological priority: get through the reproductive years intact. Anything beyond that was, from evolution’s perspective, a bonus.
Then, in the span of just a few generations, modern medicine changed everything. Antibiotics, vaccines, surgical advances, sanitation, and chronic disease management have nearly doubled our average lifespan. The average American can now expect to live close to eighty years.
But here is the catch: while medicine has extended our years, it has not rewritten our biology. The same body that was built to last forty years is now being asked to last twice that. And many of the systems that keep us strong, alert, and resilient — hormones, peptides, mitochondrial signals, immune messengers — were never meant to operate at full capacity into our seventh and eighth decades. By design, they decline.
Understanding this gap is, I believe, the foundation of modern longevity medicine. Once we see aging as the predictable consequence of evolved biology meeting unprecedented lifespan, the question is no longer whether we can intervene — but where, and how thoughtfully.
The Three Engines of Aging
While research has identified more than a dozen “hallmarks” of aging, three deeply interconnected processes drive most of what we feel and see as we get older.
Mitochondrial decline. Mitochondria are the energy-producing organelles inside every cell, and their numbers and efficiency fall steadily with age. By the time we reach our sixties, our mitochondria produce significantly less ATP — the cellular currency of energy — than they did in our twenties. Worse, aging mitochondria leak more reactive oxygen species and signal less effectively to the rest of the body. Fatigue, declining exercise tolerance, blunted recovery, and diminished cognitive sharpness all trace back, in part, to mitochondrial wear.
Chronic, low-grade inflammation. Researchers have given this phenomenon a name: inflammaging. It is not the acute, useful inflammation that helps you heal a sprained ankle. It is a persistent, smoldering inflammatory tone that develops over decades — fueled by gut barrier dysfunction, visceral fat, accumulated cellular damage, and a tired immune system. Inflammaging underlies most age-related disease, from atherosclerosis to neurodegeneration to insulin resistance.
Oxidative stress. When mitochondria leak and inflammation runs unchecked, the result is an excess of free radicals overwhelming the body’s antioxidant defenses. Over time, this damages DNA, proteins, and lipid membranes. The accumulated injury is one reason aging tissues lose their elasticity, their repair capacity, and their resilience.
These three processes are not separate. They feed one another. And they all share a common evolutionary feature: the regulatory signals that should keep them in check — including a host of peptides — are turned down sharply after midlife.
Peptides: Restoring the Signals That Time Has Quieted
Peptides are short chains of amino acids that act as messengers in the body. We make hundreds of them, and they regulate everything from immune function to tissue repair to mitochondrial health. Many decline meaningfully with age. When used carefully, in clinical settings, certain peptide therapies can help restore some of the signaling that our biology no longer prioritizes.
A few are particularly relevant to the three engines of aging described above.
Targeting mitochondrial health
MOTS-c is a peptide encoded directly within mitochondrial DNA — a remarkable detail, because it means the mitochondria themselves are sending hormone-like signals to the rest of the body. MOTS-c improves insulin sensitivity, supports metabolic flexibility, and helps regulate how cells respond to stress. Levels decline measurably with age. Restoring MOTS-c is one of the more elegant interventions we have, because it works with the body’s own mitochondrial signaling rather than around it.
SS-31 (also known as elamipretide) takes a different approach. It targets the inner mitochondrial membrane directly, binding to a phospholipid called cardiolipin that is essential for mitochondrial structure and function. By stabilizing cardiolipin, SS-31 reduces electron leak, lowers reactive oxygen species, and helps mitochondria produce ATP more cleanly. It has been studied in heart failure, mitochondrial myopathy, and age-related muscle decline. Patients often describe a return of stamina they had not felt in years.
Supporting immune resilience
Thymosin Alpha-1 is produced by the thymus, the small gland behind the breastbone where T cells mature. Beginning in adolescence, the thymus shrinks — a process called thymic involution — and by the time we are in our sixties, it is largely replaced by fat. Thymosin Alpha-1 levels fall accordingly. Restoring this peptide helps modulate the immune system, improving its ability to recognize threats while damping the chronic, low-grade activation that drives inflammaging. It is one of the most well-studied immune-supportive peptides we have.
Calming inflammation and supporting repair
BPC-157, derived from a protective sequence found in gastric juice, has shown remarkable activity in supporting tissue healing — particularly tendons, ligaments, gut lining, and blood vessels. It moderates inflammation rather than suppressing it, and it supports the angiogenesis that repair tissue requires. For patients with long-standing musculoskeletal injuries or gut barrier issues, BPC-157 is often a foundational tool.
KPV is a tripeptide — just three amino acids, lysine-proline-valine — that represents the active, anti-inflammatory tail of α-MSH, a larger hormone. Despite its size, it is potent. KPV is particularly useful in gut and skin inflammation, where its ability to quiet overactive immune signaling makes a meaningful difference for patients with inflammatory bowel conditions, eczema, and chronic gut dysfunction.
Longevity and cellular signaling
Epitalon, a tetrapeptide developed by Russian gerontologist Vladimir Khavinson, has been studied for several decades for its effects on the pineal gland, melatonin production, and telomere maintenance. Animal and early human research suggests it may support telomerase activity — the enzyme that protects the chromosomal end-caps that shorten with each cell division. Patients often report improved sleep quality and circadian rhythm regulation, both of which independently influence the pace of aging.
Pinealon, a related short peptide, focuses on the central nervous system. It supports neuronal function under conditions of oxidative stress and ischemia and has been studied for cognitive resilience in aging brains. For patients concerned about cognitive longevity, it can be a useful adjunct.
A Word on Context
Peptide therapy is not a substitute for the foundations of healthy aging — sleep, nutrient-dense food, regular movement, strength training, social connection, and the management of underlying drivers like insulin resistance, hormone imbalances, and gut health. No injection will overcome a pattern of chronic poor sleep or a diet that fuels inflammation.
These compounds are best understood as precision tools used within a comprehensive plan: identifying the specific systems that are aging fastest in a given person, and supporting them with care. They should always be sourced from licensed compounding pharmacies, prescribed by clinicians who understand the science, and integrated with thorough lab work and follow-up.
What the Evolutionary Lens Tells Us
Aging is not a disease, but the consequences of aging — the hormonal declines, the mitochondrial drift, the smoldering inflammation, the loss of resilience — are biological processes we can understand, measure, and influence. Our bodies were not designed to give us our best selves at seventy. But the elegant architecture of our biology means that, with the right inputs, we can do far more than simply age in place. We can extend our healthspan, not just our lifespan.
For my patients, this is the central question: how do we live the second half of life with the energy, clarity, and resilience we had in the first? The evolving science of peptide therapy — when used wisely — gives us one of the most promising answers we have.
To get started:
Call our office at 703-666-4144 or schedule a consultation with us.
Dr. Aleksandra Gajer
Founder, The Gajer Practice | Burke, Virginia
Board-Certified Physician | Functional & Performance Medicine
